Palisades Compounding PharmacyMarch 15, 2023

FDA 483 - Palisades Compounding Pharmacy - March 15, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Palisades Compounding Pharmacy

Record Details

Palisades Compounding Pharmacy in Pacific Palisades, CA, a producer of non-sterile drugs, was cited for significant deficiencies during an FDA inspection. Observations included inadequate segregation and cleaning practices for hazardous drug production, leading to potential cross-contamination. Additionally, the firm was found to have used expired excipients in the production of finished drug products, compromising their quality.

Company: Palisades Compounding Pharmacy
Inspection Date: March 15, 2023
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
Person: Darren S. Brown (Consumer Safety Officer)

Open in Dashboard

ID · 59444b9e-4f96-4139-b08e-3de81dbf6936